WANY
SANA icon

Wealthspire Advisors (New York)’s Sana Biotechnology SANA Stock Holding History

Wealthspire Advisors (New York)’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,030
Closed -$3.66K – 2526
2025
Q3 		$3.66K Buy
+1,030
New +$3.72K ﹤0.01% 2439

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Wealthspire Advisors (New York)'s SANA Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Sana Biotechnology (SANA) in Q4 2025, closing a stake of 1,030 shares — an estimated $3.66K sold.

Wealthspire Advisors (New York) first reported a position in SANA in Q3 2025 and held it in 1 quarter. The position peaked at $3.66K in Q3 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Sana Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,030 Sana Biotechnology shares in Q4 2025, an estimated $3.66K.
  • Wealthspire Advisors (New York) first reported a position in Sana Biotechnology in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Sana Biotechnology position peaked at $3.66K in Q3 2025.
  • 203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.